Trajectum Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Trajectum Pharma General Information

Description

Developer of a tolerance-inducing cell therapy designed to treat autoimmune inflammatory diseases. The company's therapy is built on a deep-rooted understanding of immunologic functions in health and disease to develop an off-the-shelf vaccine for RA or possibly use CAR-T cells to induce tolerance, enabling physicians to treat autoimmune inflammatory diseases in an enhanced way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • PO Box 85459
  • 3508 AL Utrecht
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trajectum Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 00000 Completed Generating Revenue
4. Seed Round 01-Jan-2020 00000 Completed Generating Revenue
3. Seed Round 01-Jul-2010 00000 00000 Completed Generating Revenue
2. Grant 01-Jun-2010 $31.3K Completed Generating Revenue
1. Spin-Off 01-Jan-2010 Completed Startup
To view Trajectum Pharma’s complete valuation and funding history, request access »

Trajectum Pharma Executive Team (2)

Name Title Board Seat Contact Info
Paul Leufkens Co-Founder and Chief Executive Officer
Willem van Eden Ph.D Scientific Director
To view Trajectum Pharma’s complete executive team members history, request access »

Trajectum Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Utrecht Holdings Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Trajectum Pharma’s complete investors history, request access »

Trajectum Pharma FAQs

  • When was Trajectum Pharma founded?

    Trajectum Pharma was founded in 2010.

  • Who is the founder of Trajectum Pharma?

    Paul Leufkens and Willem van Eden Ph.D are the founders of Trajectum Pharma.

  • Who is the CEO of Trajectum Pharma?

    Paul Leufkens is the CEO of Trajectum Pharma.

  • Where is Trajectum Pharma headquartered?

    Trajectum Pharma is headquartered in Utrecht, Netherlands.

  • What industry is Trajectum Pharma in?

    Trajectum Pharma’s primary industry is Drug Discovery.

  • Is Trajectum Pharma a private or public company?

    Trajectum Pharma is a Private company.

  • What is Trajectum Pharma’s current revenue?

    The current revenue for Trajectum Pharma is 000000.

  • How much funding has Trajectum Pharma raised over time?

    Trajectum Pharma has raised $136K.

  • Who are Trajectum Pharma’s investors?

    Utrecht Holdings has invested in Trajectum Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »